Join
Live feed
·
INSIDERFilingvia Quantisnow
Akoya BioSciences Inc. logo

Ramachandran Niro Ph.D covered exercise/tax liability with 2,006 shares, decreasing direct ownership by 0.96% to 207,924 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AKYA (Akoya BioSciences Inc.) and more on Quantisnow.